Hepatoprotective effect of resveratrol against ethanol-induced oxidative stress through induction of superoxide dismutase in vivo and in vitro
- Authors:
- Published online on: February 16, 2016 https://doi.org/10.3892/etm.2016.3077
- Pages: 1231-1238
-
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Resveratrol (RSV; 3,5,4-trihydroxystilbene) is a natural polyphenol found in grapes, red wine, peanuts and berries (1,2). RSV possesses anti-oxidative and anti-inflammatory properties and is able to modulate lipid metabolism (3–7). Therefore, a diet rich in RSV may attenuate diabetes, and cardiovascular and stress-related diseases (8–11). The liver is the major organ responsible for metabolizing nutrients in the body and is easily damaged by an imbalance in redox status (12). However, the underlying mechanism by which RSV exerts its beneficial effects on hepatic damage remains unclear.
Alcoholic drinks are widely consumed throughout the world and have been implicated in many diseases such as liver cirrhosis and liver cancer, which globally account for an equal number of cases of mortality and disability as tobacco (13). The liver is the primary organ responsible for alcohol metabolism in the human body, and alcohol is primarily metabolized in hepatocytes. Reactive oxygen species (ROS) are known to cause ethanol-induced liver damage (14,15), and a manifestation of alcoholic liver injury is lipid accumulation (16). Imbalanced lipid homeostasis, in addition to the generation of ROS, promotes the hepatic symptoms of steatosis, fibrosis, cirrhosis and hepatitis (17,18). The antioxidative properties of RSV suggest that it may be a promising protective agent against alcoholic liver disease. In order to delineate the protective effect of RSV against oxidative damage in vivo, hepatic malondialdehyde (MDA, a lipid peroxidation product) levels and histopathology of the livers of ethanol plus RSV-treated mice were examined in the present study.
Endogenous antioxidative enzymes such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) are able to protect the liver against oxidative damage (19). SOD scavenges the superoxide anion radical (O2•−) to oxygen and hydrogen peroxide (H2O2). H2O2 may then be converted into water by CAT. By contrast, GPx is able to protect the cell against oxidative stress via the reduction of H2O2 and lipid peroxides, using glutathione as an electron donor (20). The present study provides an insight into the role of RSV in the regulation of antioxidative enzyme activity and gene expression, which contribute towards the defense mechanism against ROS in hepatocytes under oxidative stress.
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that contribute towards nutrient-gene interactions, which are involved in the maintenance of metabolic homeostasis (21,22). PPARs bind to retinoid-X receptors to form heterodimers and regulate the expression of their target genes, which have PPAR-response elements (PPREs) in their promoter regions (23). PPARs consist of 3 isoforms, namely PPARα, PPARβ/δ and PPARγ (23). Among these PPARs, PPARα is expressed at a relatively high concentration in the liver, where it oxidizes fatty acids and metabolizes lipids (24,25). PPARβ/δ is involved in cell differentiation and epidermal wound healing (26–28). However, PPARγ regulates antioxidative enzyme genes, including SOD (29) and CAT (30). It has been suggested that PPARγ may serve an essential role in protecting organs against oxidative stress (31). The present study hypothesizes that RSV may display a modulatory role on PPARs in maintaining hepatic lipid homeostasis and in executing its antioxidative properties.
In the current study, the ability of RSV to modulate the activity of antioxidative enzymes in the mouse liver and in HepG2 cells was investigated. Furthermore, the effects of RSV on the expression of PPARs and the transcriptional activities of the reporter genes were evaluated using various PPREs in the 5′-upstream of the luciferase gene.
Materials and methods
Experimental animals
Thirty-two male C57BL/6J mice (6–8 weeks old, 18.5–20.3 g) were obtained from the Laboratory Animal Center of the National Yang Ming University (Taipei, Taiwan), and randomly assigned to one of four groups (n=8 per group). Two animals were housed in each cage and maintained at 25°C in under a 12-h light/dark cycle. All experimental procedures were approved by the Animal Care and Use Committee of the Chang Gung Medical Foundation (Chiayi, Taiwan) and complied with the NIH Guide for Care and Use of Laboratory Animals (National Research Council, 1996) (32). Mice in the four groups were administered daily, via oral gavage for 28 consecutive days, with the following: Ethanol (200 mg/kg); RSV (200 mg/kg; Sigma-Aldrich, St. Louis, MA, USA); ethanol + RSV (100 mg/kg each); or distilled water (control group). RSV was diluted in sterile water. Food and tap water were available ad libitum and body weight was recorded weekly throughout the experiment.
Following treatment, mice were anesthetized with CO2 and blood samples were extracted following a 12-h overnight fast. Plasma was isolated by centrifugation at 1,500 × g for 15 min and was stored at −35°C for subsequent biochemical analyses. Plasma concentrations of total cholesterol and triglycerol were determined spectrophotometrically using commercial kits (Merck Millipore, Darmstadt, Germany) according to manufacturer's instructions. The liver was rapidly removed, blotted dry, weighed, frozen in liquid nitrogen and stored at −80°C until use. To analyze antioxidative enzyme activity and expression, the liver tissue was homogenized in 10 volumes of 50 mM phosphate buffer (pH 7.4; Sigma-Aldrich) on ice using a Polytron homogenizer (model 099C-K54; Glas-Col LLC, Terre Haute, IN, USA). The homogenate was transferred into centrifuge tubes and centrifuged at 9,000 × g at 4°C for 20 min. The supernatant was separated for use in the subsequent measurement of antioxidative enzyme activity.
Measurement of MDA and hepatic lipid accumulation
Plasma levels of MDA, an oxidative stress marker, were monitored by quantifying thiobarbituric acid (TBA)-reactive substances as previously described (33). Briefly, 1 g liver tissue was homogenized in 10 ml 1.15% KCl buffer (Sigma-Aldrich). The homogenate was mixed with 1% H3PO4 (Sigma-Aldrich) and 0.6% TBA (Sigma-Aldrich), and heated at 100°C for 45 min. The samples were cooled to room temperature and combined with n-butanol (Merck Millipore). Following vigorous vortexing, the butanolic phase was centrifuged at 4,000 × g for 10 min. 1,1,3,3-Tetraethoxypropane (Merck Millipore) was used as the standard. The histology of hepatic microvesicular steatosis was assessed using the Oil Red O (Sigma-Aldrich) staining method as previously described (34).
Cell culture, cell viability and ROS assays
HepG2 is a well-differentiated human hepatocarcinoma cell line commonly used in hepatic studies. HepG2 cells were provided by Prof. An-Na Chiang and cultured in Dulbecco's Modified Eagle's Medium (HyClone; GE Healthcare, Logan, UT, USA) containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin (GE Healthcare). After 24 h of growth at 37°C in 5% CO2, cells were treated with ethanol or RSV (50, 100, 200 or 400 mM) for 24 h. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich) was used to evaluate the cytotoxic effects of ethanol and RSV (35). The ROS levels in HepG2 cells were measured using the dye, 2′,7′-dichlorodihydrofluorescein diacetate (Molecular Probes; Thermo Fisher Scientific, Inc., Waltham, MA, USA), as described previously (36). This reduced dye was added to cells at a final concentration of 10 µM. The fluorescence of the oxidized dichlorofluorescein was recorded, with an excitation wavelength of 488 nm and an emission wavelength of 525 nm, using flow cytometry (model FC500; Beckman Coulter, Inc., Brea, CA, USA). The results were expressed as the relative fluorescence intensity. Measurements of ROS levels without ethanol or RSV treatment were used as the control.
Measurement of antioxidative enzyme activity
SOD activity in the liver extracts of C57BL/6 mice or HepG2 cells was assayed using the hydroxylamine reduction method (37). The hypoxanthine/xanthine oxidase system (38) was used to measure the reduction of hydroxylamine by O2•−, which was monitored at 550 nm. One unit of SOD activity was recorded as the quantity of enzyme required to decrease the reduction of hydroxylamine by 50%. Mouse liver or HepG2 cell CAT activity in the extract was assayed using the method described by Aebi (39). Decomposition of H2O2 resulting from CAT activity was assayed by monitoring H2O2 and the reduction in absorbance at 240 nm. One unit of CAT activity was recorded as the quantity of enzyme catalyzing 1 µmol H2O2 per min at 25°C. GPx activity was quantified according to a coupled enzyme (GPx and glutathione reductase) procedure (40), which measures the decrease in absorbance at 340 nm as NADPH is converted to NADP. One unit of GPx activity was recorded as the quantity of enzyme oxidizing 1 µmol NADPH per min. The specific activity of SOD, CAT and GPx are expressed as U/mg protein. The protein content of the liver or cell extract was determined using the Bradford method (Bio-Rad Laboratories, Inc., Hercules, CA, USA) (41).
Western blot analysis
Protein levels of antioxidative enzymes and PPARs were determined using western blot analysis in HepG2 cells supplemented with ethanol and/or RSV for 24 h. Total cell protein was extracted using lysis buffer containing 1% Triton X-100, 50 mM HEPES, 6 mM EDTA, and 150 mM NaCl supplemented with complete protease inhibitor cocktail (Roche Diagnostics GmbH, Mannheim, Germany). Cell lysates were centrifuged, and the supernatants were collected. The protein concentration was determined using the Bradford method (Bio-Rad Laboratories, Inc.) using bovine serum albumin as a standard, and equal quantities of protein (30 µg) were analyzed by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (Pall Corporation, Port Washington, NY, USA). The immunoblots were blocked with 5% non-fat milk and then incubated at 4°C for 16–32 h with the following primary antibodies: Rabbit anti-human SOD polyclonal antibody (1:5,000; cat. no. ab13533; Abcam, Cambridge, UK); rabbit anti-human CAT polyclonal antibody (1:2,000; cat. no. ab16731; Abcam); goat anti-human GPx IgG (1:1,000; cat. no. sc-22145; Santa Cruz Biotechnology, Inc., Dallas, TX, USA); rabbit anti-human PPARα IgG (1:1,000; cat. no. sc-9000; Santa Cruz Biotechnology, Inc.); rabbit anti-human PPARβ/δ IgG (1:1,000; cat. no. sc-7197; Santa Cruz Biotechnology, Inc.); goat anti-human PPARγ IgG (1:1,000; cat. no. sc-1981; Santa Cruz Biotechnology, Inc.). Following the washing stage, the blots were incubated with horseradish peroxidase-conjugated secondary antibodies (Sigma-Aldrich) for 1 h at 4°C, and the target protein bands were visualized using Western Lightning Plus-Enhanced Chemiluminescence reagents (PerkinElmer, Inc., Waltham, MA, USA). The blots were then stripped for further probing, using β-actin (rabbit anti-human β-actin polyclonal antibody; cat. no. ab189073; Abcam) as an internal control. Relative intensities of protein bands were quantified by densitometry using ImageQuant software version 5.0 (Molecular Dynamics, Sunnyvale, CA, USA).
RNA extraction and quantitative polymerase chain reaction (qPCR) analysis
Total RNA was extracted from HepG2 cells using TRIzol® reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. Total RNA (2 µg) was reverse transcribed using Moloney murine leukemia virus reverse transcriptase (Invitrogen; Thermo Fisher Scientific, Inc.). The resulting cDNA (1 µg) was used as a template for qPCR analysis using SYBR Green Master Mixture (QuantiTect SYBR Green PCR kit 200; cat. no. 204143; Qiagen, Inc., Valencia, CA, USA) in a Roche LightCycler system (Roche Diagnostics GmbH). The specific primers (50 µM in 0.08 µl) for SOD, CAT and GPx genes were used as previously described (42). The following primer sequences were used: Cu/Zn-SOD forward, 5′-CAGGTCCTCACTTCAATCC-3′ and reverse, 5′-CCAAACGACTTCCAGCAT-3′; CAT forward, 5′-CGAAGGCGAAGGTGTTTG-3′ and reverse, 5′-AGTGTGCGATCCATATCC-3′; GPx forward, 5′-CACAACGGTGCGGGACTA-3′ and reverse, 5′-CATTGCGACACACTGGAGAC-3′; and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forward, 5′-GAAGGTGAAGGTCGGAGTC-3′ and reverse, 5′-GAAGATGGTGATGGGATTTC-3′. Comparative assessment of target gene mRNA expression was performed using GAPDH mRNA as an internal control. Reaction conditions were 95°C for 10 min, followed by 40 cycles of 95°C for 20 sec, 60°C for 20 sec and 72°C for 20 sec. Relative quantification of antioxidative enzyme mRNA was calculated using the Cq method (ratio = 2 − (Cq (antioxidant enzyme) - Cq (GAPDH)) as described previously (43).
Transient transfection assays
HepG2 cells were transiently transfected with 0.2 µg tk-PPREx-Luc reporter plasmid and 0.2 µg PPARα (pGShPPARα), PPARβ (pCMX-hPPARβ/δ) or PPARγ (pCMX-hPPARγ) expression vectors, which were constructed by Prof. An-Na Chiang's laboratory. For each transfection, the internal control vector, pCMV-β-gal, was also co-transfected. The luciferase assay was measured using a luminometer (EG&G Berthold; Berthold Technologies USA LLC, Oak Ridge, TN, USA) and normalized against the activity of β-galactosidase (44).
Statistical analysis
Data are presented as the mean ± standard error. Each experiment was repeated at least three times. Statistical analysis between two groups was performed using the Student's t-test. One-way analysis of variance combined with Tukey's multiple-comparison test was used to evaluate the statistical significance of differences among the four groups. Statistical analysis was performed using SPSS software version 17.0 (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Effect of ethanol and RSV on plasma lipid profile and hepatic antioxidative enzyme activity
Compared with the control mice, no significant differences were detected in the body weight and concentrations of plasma cholesterol levels among the groups (Table I). However, plasma triglyceride and MDA levels were 75.3 and 56.1% higher, respectively, in the ethanol-treated mice in comparison with the control mice (Table I). After 28 days of treatment, mice in the RSV group presented a 79.5% increase in SOD activity; however, no change was observed in the ethanol and ethanol + RSV groups. Moreover, ethanol and RSV exerted no significant effect on CAT and GPx activity compared with the control group in the livers of C57BL/6 mice. Furthermore, lipid accumulation was markedly increased in the liver of mice treated with ethanol, moderately increased in mice treated with ethanol + RSV and remained unchanged in mice treated with RSV (Fig. 1).
Table I.Effect of ethanol and resveratrol on plasma lipid profile and hepatic antioxidative enzyme activity in vivo. |
Effect of ethanol and RSV on cell viability and ROS production
No significant alteration of cell viability was detected by the MTT assay in the HepG2 cells exposed to ethanol, RSV or ethanol + RSV (Fig. 2A). By contrast, ethanol treatment appeared to enhance ROS production in a dose-dependent manner (Fig. 2B). However, no significant change in ROS production was observed in the ethanol + RSV group. This indicates that RSV is able to scavenge ROS from ethanol-induced ROS generation.
Effect of ethanol and RSV on the activity and expression of antioxidative enzymes in HepG2 cells
To assess whether antioxidative enzymes are involved in RSV-mediated protection against oxidative stress, the activity of SOD, CAT and GPx was determined in HepG2 cells. As presented in Fig. 3, SOD activity significantly increased in cells exposed to RSV in comparison with the control (P<0.05), whereas the activity of CAT and GPx was not affected by ethanol or RSV treatment. The expression levels of SOD, CAT, and GPx protein (Fig. 4A–C) and mRNA (Fig. 4D–F) in HepG2 cells were determined by western blot and qPCR analysis. In comparison with the control cells, the expression levels of SOD protein and mRNA were 1.9- and 1.95-fold higher in the RSV group, respectively. There was no change in the expression of CAT and GPx in the three experimental groups in comparison with the control group.
Effect of ethanol and RSV on the protein transactivation activity of PPARs
To determine the mechanism underlying the induction of SOD gene expression by RSV, the expression and transactivation activity of PPARs in HepG2 cells was determined. PPARα, PPARβ and PPARγ protein expression was not affected in cells treated with ethanol and/or RSV (Fig. 5A and B). However, the transfection of RSV-treated HepG2 cells with the tk-PPREγ-Luc reporter construct and pCMX-hPPARγ resulted in a 2.1-fold increase in promoter activity in comparison with the untreated control cells (Fig. 5C). The treatment of HepG2 cells with 200 mM ethanol alone or 100 mM ethanol + 100 mM RSV did not exert any significant effect on PPAR transactivation.
Discussion
Alcoholic drinks typically range between ~4.5% ethanol (900 mM) in beer and ~12% ethanol (2 M) in wine (45). A large quantity of ingested ethanol circulates to the liver via the portal vein and creates a state of oxidative stress and lipid accumulation in hepatocytes (14,46). In the present study, plasma triglyceride levels and MDA generation were increased in ethanol-treated mice, indicating that ethanol causes lipid metabolism disorder and increases lipid peroxidation in vivo. Oil Red O staining identified RSV-attenuated ethanol-induced lipid accumulation in the liver, which may be the cause or effect of ethanol on liver damage. The ethanol + RSV group had a lower accumulation of lipids in the liver compared with the ethanol treated group.
An imbalance of redox status may result in a wide range of health complications and various pathophysiological syndromes (47). Ethanol-induced oxidative stress causes liver damage in alcoholism (47). RSV, a widely used nutritional component, possesses various biological functions, including antioxidative effects (10). A previous study demonstrated that RSV inhibits foam cell formation via the suppression of ROS generation in macrophages (48). The present study aimed to determine whether RSV is able to prevent the ethanol-induced oxidative stress in hepatocytes.
An endogenous antioxidant system composed of antioxidative enzymes such as SOD, CAT and GPx, is responsible for the protection against free radical damage in vivo (49). The results of the present study suggest that the protective effect of RSV against ethanol-induced liver damage results from its ability to induce the activity of hepatic SOD. This was previously indicated in a study by Kasdallah-Grissa et al (50) who reported that the hepatic activity of SOD, CAT and GPx was suppressed in ethanol-treated rats, which was reversed by treatment with RSV. In the current study, the mechanisms underlying the protective action of RSV against oxidative stress, using HepG2 cells as the hepatic cellular model, were investigated. The results demonstrated that ethanol enhances ROS in a dose-dependent manner, and RSV protects cells against oxidative damage by suppressing ROS generation. Moreover, in the present study, RSV administration was demonstrated to enhance the activity and expression of SOD in comparison with the control group.
Previously, RSV has been observed to selectively activate PPARs in neuronal cells and adipocytes (51,52). The SOD gene has known to be a PPARγ target gene (29). The present study hypothesized that RSV activates hepatic SOD gene expression through PPAR activation. The effect of RSV on PPAR expression and its transcriptional activation was investigated using western blot analysis and a luciferase assay. It was observed that RSV significantly upregulated PPARγ activity; however, its fundamental mechanism still remains to be elucidated.
In summary, the present study demonstrates that RSV serves an essential role in mitigating ethanol-induced hepatic oxidative stress in vivo and in vitro. This protective effect may result from the suppression of lipid peroxidation and accumulation, and the activation of SOD gene expression. Furthermore, it may be suggested that PPARγ activation is involved in RSV-enhanced SOD gene regulation. The results in the current study identify novel mechanisms underlying the protective actions of RSV and provide a novel insight into the prevention of ethanol-induced hepatic damage and liver disease.
Acknowledgements
The present study was supported by the Chang Gung Medical Foundation of Taiwan (grant no. CMRP:G6A0311). The authors thank Prof. An-Na Chiang (Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan) for providing HepG2 cells and technical assistance.
References
Pirola L and Fröjdö S: Resveratrol: One molecule, many targets. IUBMB Life. 60:323–332. 2008. View Article : Google Scholar : PubMed/NCBI | |
Shakibaei M, Harikumar KB and Aggarwal BB: Resveratrol addiction: To die or not to die. Mol Nutr Food Res. 53:115–128. 2009. View Article : Google Scholar : PubMed/NCBI | |
Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK and Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun. 309:1017–1026. 2003. View Article : Google Scholar : PubMed/NCBI | |
Lasa A, Schweiger M, Kotzbeck P, Churruca I, Simón E, Zechner R and Portillo MP: Resveratrol regulates lipolysis via adipose triglyceride lipase. J Nutr Biochem. 23:379–384. 2012. View Article : Google Scholar : PubMed/NCBI | |
Mikuła-Pietrasik J, Kuczmarska A, Rubiś B, Filas V, Murias M, Zieliński P, Piwocka K and Książek K: Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms. Free Radic Biol Med. 52:2234–2245. 2012. View Article : Google Scholar : PubMed/NCBI | |
Park DW, Kim JS, Chin BR and Baek SH: Resveratrol inhibits inflammation induced by heat-killed Listeria monocytogenes. J Med Food. 15:788–794. 2012. View Article : Google Scholar : PubMed/NCBI | |
Voloshyna I, Hussaini SM and Reiss AB: Resveratrol in cholesterol metabolism and atherosclerosis. J Med Food. 15:763–773. 2012. View Article : Google Scholar : PubMed/NCBI | |
Bhatt JK, Thomas S and Nanjan MJ: Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 32:537–541. 2012. View Article : Google Scholar : PubMed/NCBI | |
Chang CC, Chang CY, Huang JP and Hung LM: Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats. Chin J Physiol. 55:192–201. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sadruddin S and Arora R: Resveratrol: Biologic and therapeutic implications. J Cardiometab Syndr. 4:102–106. 2009. View Article : Google Scholar : PubMed/NCBI | |
Tomé-Carneiro J, Gonzálvez M, Larrosa M, García-Almagro FJ, Avilés-Plaza F, Parra S, Yáñez-Gascón MJ, Ruiz-Ros JA, García-Conesa MT, Tomás-Barberán FA and Espín JC: Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial. Mol Nutr Food Res. 56:810–821. 2012. View Article : Google Scholar : PubMed/NCBI | |
Cesaratto L, Vascotto C, Calligaris S and Tell G: The importance of redox state in liver damage. Ann Hepatol. 3:86–92. 2004.PubMed/NCBI | |
Room R, Babor T and Rehm J: Alcohol and public health. Lancet. 365:519–530. 2005. View Article : Google Scholar : PubMed/NCBI | |
Cahill A, Cunningham CC, Adachi M, Ishii H, Bailey SM, Fromenty B and Davies A: Effects of alcohol and oxidative stress on liver pathology: The role of the mitochondrion. Alcohol Clin Exp Res. 26:907–915. 2002. View Article : Google Scholar : PubMed/NCBI | |
Hoek JB and Pastorino JG: Cellular signaling mechanisms in alcohol-induced liver damage. Semin Liver Dis. 24:257–272. 2004. View Article : Google Scholar : PubMed/NCBI | |
Wu KC, Liu J and Klaassen CD: Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation. Toxicol Appl Pharmacol. 262:321–329. 2012. View Article : Google Scholar : PubMed/NCBI | |
de Alwis NM and Day CP: Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol. 48(Suppl 1): S104–S112. 2008. View Article : Google Scholar : PubMed/NCBI | |
Mann RE, Smart RG and Govoni R: The epidemiology of alcoholic liver disease. Alcohol Res Health. 27:209–219. 2003.PubMed/NCBI | |
Kumar M, Sharma VL, Sehgal A and Jain M: Protective effects of green and white tea against benzo(a)pyrene induced oxidative stress and DNA damage in murine model. Nutr Cancer. 64:300–306. 2012. View Article : Google Scholar : PubMed/NCBI | |
Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary MD and Remacle J: Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev. 3:283–297. 1990. View Article : Google Scholar | |
Jonker JW, Suh JM, Atkins AR, Ahmadian M, Li P, Whyte J, He M, Juguilon H, Yin YQ, Phillips CT, et al: A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature. 485:391–394. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kidani Y and Bensinger SJ: Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev. 249:72–83. 2012. View Article : Google Scholar : PubMed/NCBI | |
Berger J and Moller DE: The mechanisms of action of PPARs. Annu Rev Med. 53:409–435. 2002. View Article : Google Scholar : PubMed/NCBI | |
Huang J, Jia Y, Fu T, Viswakarma N, Bai L, Rao MS, Zhu Y, Borensztajn J and Reddy JK: Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J. 26:628–638. 2012. View Article : Google Scholar : PubMed/NCBI | |
Takahashi N, Senda M, Lin S, Goto T, Yano M, Sasaki T, Murakami S and Kawada T: Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice. Mol Nutr Food Res. 55:1791–1797. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chong HC, Tan MJ, Philippe V, Tan SH, Tan CK, Ku CW, Goh YY, Wahli W, Michalik L and Tan NS: Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing. J Cell Biol. 184:817–831. 2009. View Article : Google Scholar : PubMed/NCBI | |
Man MQ, Barish GD, Schmuth M, Crumrine D, Barak Y, Chang S, Jiang Y, Evans RM, Elias PM and Feingold KR: Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol. 128:370–377. 2008. View Article : Google Scholar : PubMed/NCBI | |
Müller R, Rieck M and Müller-Brüsselbach S: Regulation of cell proliferation and differentiation by PPARβ/δ. PPAR Res. 2008:6148522008. View Article : Google Scholar : PubMed/NCBI | |
Yoo HY, Chang MS and Rho HM: Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene. 234:87–91. 1999. View Article : Google Scholar : PubMed/NCBI | |
Girnun GD, Domann FE, Moore SA and Robbins ME: Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol. 16:2793–2801. 2002. View Article : Google Scholar : PubMed/NCBI | |
Jung KH, Chu K, Lee ST, Kim SJ, Song EC, Kim EH, Park DK, Sinn DI, Kim JM, Kim M and Roh JK: Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J Pharmacol Exp Ther. 322:1051–1058. 2007. View Article : Google Scholar : PubMed/NCBI | |
National Research Council (US) Institute for Laboratory Animal Research: Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US). 1996. | |
Lin KY, Chen YL, Shih CC, Pan JP, Chan WE and Chiang AN: Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages. J Cell Biochem. 86:258–267. 2002. View Article : Google Scholar : PubMed/NCBI | |
Cui W, Chen SL and Hu KQ: Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res. 2:95–104. 2010.PubMed/NCBI | |
Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47:936–942. 1987.PubMed/NCBI | |
LeBel CP, Ischiropoulos H and Bondy SC: Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol. 5:227–231. 1992. View Article : Google Scholar : PubMed/NCBI | |
Oyanagui Y: Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem. 142:290–296. 1984. View Article : Google Scholar : PubMed/NCBI | |
Chen J, Rogers SC and Kavdia M: Analysis of kinetics of dihydroethidium fluorescence with superoxide using xanthine oxidase and hypoxanthine assay. Ann Biomed Eng. 41:327–337. 2013. View Article : Google Scholar : PubMed/NCBI | |
Aebi H: Catalase in vitro. Methods Enzymol. 105:121–126. 1984. View Article : Google Scholar : PubMed/NCBI | |
Flohé L and Günzler WA: Assays of glutathione peroxidase. Methods Enzymol. 105:114–121. 1984. View Article : Google Scholar : PubMed/NCBI | |
Bradford MM: A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI | |
Xu CL, Wang YZ, Guo J, Liu JX and Feng J: Comparison of age-related differences in expression of antioxidant enzyme mRNA and activity in various tissues of pigs. Comp Biochem Physiol B Biochem Mol Biol. 147:445–451. 2007. View Article : Google Scholar : PubMed/NCBI | |
Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, Agrawal A, Valente AJ and Chandrasekar B: Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem. 282:27229–27238. 2007. View Article : Google Scholar : PubMed/NCBI | |
Young DC, Kingsley SD, Ryan KA and Dutko FJ: Selective inactivation of eukaryotic β-galactosidase in assays for inhibitors of HIV-1 TAT using bacterial β-galactosidase as a reporter enzyme. Anal Biochem. 215:24–30. 1993. View Article : Google Scholar : PubMed/NCBI | |
Pochareddy S and Edenberg HJ: Chronic alcohol exposure alters gene expression in HepG2 cells. Alcohol Clin Exp Res. 36:1021–1033. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tsukamoto H and Lu SC: Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 15:1335–1349. 2001. View Article : Google Scholar : PubMed/NCBI | |
Comporti M, Signorini C, Leoncini S, Gardi C, Ciccoli L, Giardini A, Vecchio D and Arezzini B: Ethanol-induced oxidative stress: Basic knowledge. Genes Nutr. 2:101–109. 2010. View Article : Google Scholar | |
Park DW, Baek K, Kim JR, Lee JJ, Ryu SH, Chin BR and Baek SH: Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1. Exp Mol Med. 41:171–179. 2009. View Article : Google Scholar : PubMed/NCBI | |
Matés JM, Pérez-Gómez C and de Núñez Castro I: Antioxidant enzymes and human diseases. Clin Biochem. 32:595–603. 1999. View Article : Google Scholar : PubMed/NCBI | |
Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, El May M, Gharbi N, Kamoun A and El-Fazaâ S: Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci. 80:1033–1039. 2007. View Article : Google Scholar : PubMed/NCBI | |
Cheng G, Zhang X, Gao D, Jiang X and Dong W: Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett. 451:105–108. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kennedy A, Overman A, Lapoint K, Hopkins R, West T, Chuang CC, Martinez K, Bell D and McIntosh M: Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J Lipid Res. 50:225–232. 2009. View Article : Google Scholar : PubMed/NCBI |
Related Articles
- Protective effect of black garlic extracts on tert-Butyl hydroperoxide-induced injury in hepatocytes via a c-Jun N-terminal kinase-dependent mechanism
- Effects of the cyclophilin-type peptidylprolyl cis-trans isomerase from Pyropia yezoensis against hydrogen peroxide-induced oxidative stress in HepG2 cells
- Ameliorative effects of pomegranate on carbon tetrachloride hepatotoxicity in rats: A molecular and histopathological study
- Oxidative stress is insignificant in N1S1-transplanted hepatoma despite markedly declined activities of the antioxidant enzymes.
- Long-term streptozotocin-induced diabetes in rats leads to severe damage of brain blood vessels and neurons via enhanced oxidative stress